Great Basin Bordetella Direct Test
Bordetella Pertussis Dna Assay System. 510(k) K170284, from Great Basin Scientific, Inc. (Salt Lake City, UT). Product code OZZ, class 2.
As of Nov 20, 2026, K170284 is an FDA 510(k) held by Great Basin Scientific, Inc., substantially equivalent on Mar 31, 2017 after 60 days, with no recalls tied to it in FDA's recall database.
- Review time: 60 days
- Recalls: 0
The Great Basin Bordetella Direct Test is a qualitative in vitro diagnostic test for the detection of Bordetella pertussis DNA from nasopharyngeal swab specimens obtained from patients suspected of having a respiratory tract infection attributable to B. pertussis. The Bordetella Direct Test is performed on the PA500 Portrait Analyzer and utilizes PCR amplification of the insertion sequence IS481.
- Illumigene Pertusis Dna Amplification Assay, Illumigene Pertussis External Control Kit, Illumipro-10 Automated IsothermaK133673 · Meridian Bioscience, Inc. · Mar 25, 2014
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jan 30, 2017
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.3980
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files